PhD, MSc, BSc
I joined OVG in December 2021 as a Project manager to ensure projects are delivered on time, within budget and in compliance with regulatory requirements.
Before joining OVG, from 2008 till 2013 I was a scientist at the Cell Differentiation and Tumorigenesis research group headed by Prof Achim Leutz and was awarded a PhD fellowship from the International PhD Program at Max Delbruck Center for Molecular Medicine and Humboldt University, Berlin, Germany.
After completing my PhD, I worked as a postdoctoral researcher at Prof Paresh Vyas research group Biology and Treatment of Human Myeloid Cancers at the MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine. I worked on research projects aiming to understand the mechanisms of blood cell development and how these mechanisms get deregulated in leukaemia.
Lachowiez CA. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39
Juban G. et al, (2021), Haematologica, 106, 1106 - 1119
Stoilova B. et al, (2020), Clinical Lymphoma, Myeloma & Leukemia, 20, S7 - S7
Phase Ib/II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax plus /- azacitidine in IDH1-mutated hematologic malignancies.
Lachowiez CA. et al, (2020), JOURNAL OF CLINICAL ONCOLOGY, 38
C/EBPalpha and GATA-2 mutations induce bi-lineage acute erythroid leukemia through transformation of a neomorphic neutrophil-erythroid progenitor
NERLOV C. et al, (2020), Cancer Cell